6 July 2022 Marvin Tanenbaum elected as EMBO member Back to news Marvin Tanenbaum – group leader at the Hubrecht Institute and Oncode Investigator – has been elected as a member of The European Molecular Biology Organization (EMBO). He has been rewarded with this position because of his outstanding contribution to the life sciences. Tanenbaum will be formally introduced as EMBO member during the EMBO Members’ Meeting in October 2022 in Heidelberg. The European Molecular Biology Organization (EMBO) is an international organization of life scientists. Its goal is to support life science research in many ways, amongst which supporting talented researchers at all stages of their career. This year, EMBO rewarded 67 distinguished scientists from 22 different countries with the lifelong honor of the EMBO membership. “The new EMBO Members and Associate Members are exceptional scientists, who carry out leading research across a variety of fields, ranging from cell biology and cancer to vaccine development and machine learning.” says EMBO Director Fiona Watt. She adds: “I am delighted to welcome them to EMBO and I know that they will enrich the life of the organization immensely.” Tanenbaum : “Being an EMBO member is an honor and a great opportunity to contribute to science in Europe. But for me the most exciting part of it is to meet many new great scientists across Europe in fields that I normally don’t interact with much. I hope to learn a lot from these meetings, to broaden my horizon, and potentially initiate new exciting collaborations.” The research of Tanenbaum’s group focuses on various aspects of gene expression, to gain a better view on how this affects cellular functioning. Furthermore, they develop and use several innovative techniques, to get an even deeper understanding of these processes. Marvin Tanenbaum is group leader at the Hubrecht Institute and Oncode Investigator.
